McLean Hospital
Belmont, Massachusetts, 02478, United States
NCT Number: NCT02346539
The investigators will determine whether an acute dose of nicotine, in the form of the nicotine lozenge, impacts brain and behavioral measures of mood and reward responsiveness in individuals with major depressive disorder.
Looking for future studies?
Notify Me18 year–45 year
All sexes
Interventional
Phase 1
Belmont, Massachusetts, 02478, United States
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
for subjects with Major Depressive Disorder:
Inclusion criteria
for Healthy Controls
Exclusion criteria
Single Acute dose
Other names: Nicotine lozenge
Time frame: Participants will be assessed during 2 fMRI scanning sessions, an expected average of 2 weeks.
Nicotine will enhance the fMRI BOLD response to monetary reinforcers relative to placebo administration
Mclean Hospital
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04777006
Behavior, Behavioral Symptoms
Neno, Neno District, Malawi
View Trial DetailsNCT06981000
Anxiety, Anxiety Disorders
Copenhagen, Denmark
View Trial DetailsNCT04182061
Anxiety Disorder, Anxiety Disorders
Madrid, Spain
View Trial DetailsNCT03626103
Behavior, Behavioral Symptoms
New Haven, Connecticut, United States
View Trial Details